Associate Professor of Nephrology, PhD and Habilitated Doctor in Nephrology at the "Carol Davila" University of Medicine and Pharmacy in Bucharest and attending physician (consultant in Nephrology and Internal Medicine) at a university-affiliated tertiary-care hospital. Former secretary of the Romanian Society of Nephrology and currently member of the society board.
Research interest in: chronic kidney disease, renal anemia, intravenous iron therapy, mineral metabolism disorders in chronic kidney disease, oxidative stress in kidney disease and glomerular diseases.
Prf. Chengming Fan is a Surgeon in the Department of Cardiovascular Surgery at Central South University. HIs current basic research interests include treatment of ischemic heart disease with human induced pluripotent stem cells (hiPSC)-related strategy and with preclinical animal models.
Dr. Bang-Gee Hsu obtained his MD from the Chinese Medical University, Taichung, Taiwan (1989 - 1996) and his PhD from the Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan (2003-2006).
Dr. Hsu is currently Professor at the School of Medicine, Tzu Chi University, Hualien, Taiwan (2015-present), Director of the Department of Internal Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan (2018-present), and Director of the Division of Nephrology Department of Internal Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan (2014-present).
His research interests include Nephrology, Critical Care Medicine and Internal Medicine.
Brittany N. Lasseigne, PhD is an Assistant Professor of Cell, Developmental and Integrative Biology at The University of Alabama at Birmingham School of Medicine. She trained in Biotechnology, Science, and Engineering at Mississippi State University (B.S.) and the University of Alabama in Huntsville (Ph.D.) and completed a postdoctoral fellowship in genetics and genomics at the HudsonAlpha Institute for Biotechnology.
Her lab develops and applies genomic- and data-driven strategies (including single-cell and long-read sequencing) to discover biological signatures that might be used to improve patient care and provide insight into the cellular and molecular processes contributing to disease, especially for diseases impacting the brain and/or kidney. Their recent work includes prioritizing drug repurposing candidates for cancers and polycystic kidney disease, evaluating preclinical models and cross-species transcriptomic signatures to improve disease modeling, and applying single-cell and long-read technologies to neurological disease tissues to understand the role that context plays in disease etiology, progression, and treatment.
The Lasseigne Lab is currently focused on integrating genomics data, functional annotations, and patient information with machine learning and regulatory network approaches across diseases that impact the brain or kidney to discover novel mechanisms in disease etiology and progression, identify genome-driven therapeutic targets and opportunities for drug repositioning and repurposing, determine clinically-relevant biomarkers, and understand how cellular context contributes to these diseases. Collectively, these distinct projects all apply genetics and genomics to human diseases and build tools to accelerate future research. Their lab also develops data science software and analytical pipelines that are open-source, well-documented, and hosted by third-party code distributors, critical for facilitating reproducibility and enabling the research community to use the methods they develop.
Prof. Marunaka is the President and the Representative Director, Director of Clinical, and Director of Medical Research Institute, Kyoto Industrial Health Association; Professor, Research Organization of Science and Technology, Ritsumeikan University; Professor Emeritus, Kyoto Prefectural University of Medicine; Former President, Physiological Society of Japan. Former President, International Society of Cancer Metabolism. MD (1979), PhD (1985), Kyoto Prefectural University of Medicine; National License of Physician and Surgeon, Japan (1979). He was Professor and Chairperson, Departments of Molecular Cell Physiology and Bio-Ionomics, Kyoto Prefectural University of Medicine, Japan, and Director and Professor, Japan Institute for Food Education and Health, St. Agnes’ University. He was awarded “Vebleo Nanomedicine Scientist Award” (Sweden), “Marco Polo della Scienza Italiana” (Italy), The Premier's Research Excellence Award (Canada), Scholar Award (Medical Research Council of Canada) and Research Award from National Kidney Foundation of USA. He has obtained more than 60 research grants, published more than 270 peer reviewed articles, and provided more than 30 invited plenary lectures at international congresses and research conferences. h-index 47, i10-index 190, Citation 7498
Laurent Metzinger has completed his PhD in Biological Sciences and Pharmaceutical studies in Strasbourg, France and was a postdoctoral fellow from the University of Oxford (UK) in a leading lab on Duchenne muscular Dystrophy (Pr. Kay Davies). He works on microRNA regulation in the HEMATIM team in Amiens, and focuses on anemia and related vascular disorders associated with Chronic Kidney DIsease. He has authored some of the first papers showing a role for microRNAs in CKD and published in reputed journals, including Nature and Cell. He teaches Biochemistry, Genetics and Molecular Biology in the Pharmacy School of Amiens (Université de Picardie Jules Verne).
Dr. Giribabu Nelli is a Senior Lecturer within the Department of Physiology at Universiti Malaya.
Hi primary research areas include, Reproductive Biology, Diabetes and their complications, and Natural Products Research.
Professor of Nephrology and Consultant Physician at the University of Perugia
Academic Degrees:
Doctoral Degree in Medicine and Surgery (MD) from the Faculty of Medicine and Surgery, University of Perugia, Italy
Master of Science (MSc) from The Faculty of Medicine, University of Newcastle upon Tyne, Newcastle Upon Tyne, United Kingdom
Dottore di Ricerca (PhD) in Applied Pathophysiology from The University of Florence, Florence, Italy
Scientific Interests:
Renal and Cardiovascular Diseases, Diabetes, Hypertension, Clinical Epidemiology
Dr. Chih-Chung Shiao is an associate professor and a nephrologist.
He currently is the deputy superintendent of medical research and education department, chairman of the academic research committee, and attending physician of the Nephrology Division in Camillian Saint Mary’s Hospital Luodong, Taiwan.
Dr. Chih-Chung Shiao has published a total of more than 70 papers in SCI journals. His research interests cover acute kidney injury, autonomic cardiac function, critical care nephrology, heart failure, survival, chronic kidney disease, and uremia.
Professor Edward Smith is an Associate Professor in the Department of Medicine, University of Melbourne and Senior Scientist at the Kincaid-Smith Renal Laboratories, Department of Nephrology, The Royal Melbourne Hospital. He is interested in mineral metabolism and kidney disease.
Dr Lo’ai Tawalbeh (IEEE SM) completed his PhD degree in Electrical & Computer Engineering from Oregon State University in 2004, and MSc in 2002 from the same university with GPA 4/4. Dr. Tawalbeh is currently an Associate professor at the department of Computing and Cyber Security at Texas A&M University-San Antonio. Before that he was a visiting researcher at University of California-Santa Barbra. Since 2005 he taught/developed more than 25 courses in different disciplines of computer engineering and science with focus on cyber security for the undergraduate/graduate programs at: NewYork Institute of Technology (NYIT), DePaul’s University, and Jordan University of Science and Technology. Dr. Tawalbeh won many research grants and awards with over than 2 Million USD. He has over 80 research publications in refereed international Journals and conferences.